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BIOMEDICAL REPORTS
Abstract. Adult hepatocytes are polarised with their apical 
and basolateral membranes separated from neighbouring cells 
by tight junction proteins. Although efficient differentiation of 
pluripotent stem cells to hepatocytes has been achieved, the 
formation of proper polarisation in these cells has not been 
thoroughly investigated. In the present study, human embry‑
onic stem cells (hESCs) and human mesenchymal stem cells 
(hMSCs) were differentiated to hepatocyte‑like cells and the 
derived hepatocytes were characterised for mature hepatocyte 
markers. The secretion of hepatic proteins, expression of 
hepatic genes and the functional hepatic polarisation of stem 
cell‑derived hepatocytes, foetal hepatocytes and the HepG2 
hepatic cell line were evaluated and the different lines were 
compared. The results indicate that hESC‑derived hepatocytes 
are phenotypically more robust and functionally more efficient 
compared with the hMSC‑derived hepatocytes, suggesting 
their suitability for toxicity studies.
Introduction
Currently, there is significant interest in generating mature 
hepatocytes from stem cells either for disease modelling, 
predictive drug toxicology studies or, in the longer term, for 
transplantation. The scarcity of adult human hepatocytes, 
and their functional deterioration and poor replication in 
culture are the main motivations behind this research (1). 
The extensive in vitro replication capability of pluripotent 
stem cells has made them an attractive alternative cell source. 
Numerous studies show that embryonic stem cells (ESCs), 
induced pluripotent stem cells and adult stem cells can be 
differentiated towards the hepatic lineage (2‑4).
Hepatocytes are used primarily in the pharmaceutical 
industry for screening new compounds. This screening helps 
to eliminate potentially toxic drugs at the preliminary stage, 
avoiding unanticipated effects at later stages of clinical trials 
and reducing the time and expense required for the commer‑
cialisation of new drugs. Due to their simplicity, commonly 
used materials, such as microsomal fractions, hepatocyte 
suspensions and short‑term cultures, have their limitations 
for evaluating complex toxic reactions (5). A highly polarised 
hepatocyte model is necessary for evaluating hepatobiliary 
excretion and potential liver injury, and studying viral infec‑
tions (6,7).
Polarised hepatocytes have an asymmetric cell membrane 
characterised by the segregated expression of membrane 
proteins in different domains. Tight junctions are responsible for 
this segregation of apical and basolateral membrane domains. 
Apical poles of adjacent hepatocytes join to form a continuous 
channel, which is the bile canaliculi that harbours numerous 
transport proteins, such as multidrug resistance‑associated 
protein 2 (MRP2), to excrete bile salts from the cell. The basal 
membrane domain (sinusoidal pole) is responsible for the 
uptake of recycled biliary salts and nutrients, and the secre‑
tion of various hepatic proteins into the blood circulation. 
Bile canaliculi formation is an important feature of polarised 
hepatocytes and can be observed microscopically as chan‑
nels between adjacent hepatocytes. The formation of hepatic 
polarity in cultured cells can be assessed by the expression of 
the tight junction [zona occludin 1 (ZO‑1)], localised expres‑
sion of transport protein MRP2 to the bile canalicular side and 
by the excretion and localisation of traceable compounds, such 
as fluorescein, within bile canaliculi.
In the present study, human ESCs (hESCs) and mesenchymal 
stem cells (hMSCs) were differentiated to hepatocyte‑like 
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cells. These differentiated stem cells were examined for the 
expression of hepatic genes and functions. Hepatic polarisa‑
tion, particularly the expression of tight junction protein ZO‑1, 
the apical bile canalicular MRP2, bile canalicular protein 
dipeptidyl peptidase 4 (DPP4) and the excretion of fluorescein 
by these stem cell‑derived hepatocytes was extensively evalu‑
ated and compared with that of the human foetal hepatocytes 
and HepG2 cells.
Materials and methods
hESC culture and hepatic differentiation (monolayer 
culture). The RCM1 hESC line was cultured and propagated 
in Matrigel‑coated plates with mTeSR 1 medium (Stem Cell 
Technologies, Vancouver, BC, Canada) under feeder‑free 
and serum‑free conditions as previously described (8). 
Differentiation was initiated when the hESCs reached ~30% 
confluency by replacing MTeSR‑1 medium with priming 
medium [RPMI‑1640 medium (Biosera, ZI du Bousquet, 
Boussens, France) containing 1X B27 supplement (Invitrogen 
Life Technologies, Carlsbad, CA, USA), 100 ng/ml Activin A 
(PeproTech, Rocky Hill, NJ, USA) and 50 ng/ml Wnt‑3A 
(PeproTech)] for 3 days. Cells were subsequently maintained 
in differentiation medium [knockout Dulbecco's modified 
eagle medium (DMEM) (Invitrogen Life Technologies) 
containing 20% serum replacement, 1 mmol/l glutamine, 1% 
non‑essential amino acids, 0.1 mmol/l β‑mercaptoethanol (all 
from Invitrogen Life Technologies) and 1% dimethyl sulfoxide 
(DMSO) (Sigma, St. Louis, MO, USA)] for 5 days. Finally, 
the cells were cultured in maturation medium [L15 medium 
containing 8.3% fetal bovine serum (FBS), 8.3% tryptose 
phosphate broth, 10 mmol/l hydrocortisone 21‑hemisucci‑
nate, 1 mmol/l insulin (all from Sigma), 2 mmol/l glutamine, 
10 ng/ml hepatocyte growth factor (PeproTech) and 20 ng/ml 
oncostatin M (PeproTech)] for 9 days. Medium was changed 
every 2 days during differentiation.
Collagen sandwich culture of differentiated hESC (sandwich 
culture). Neutralised collagen solution (100 µl, 1 mg/ml) (Roche 
Diagnostics, Basel, Switzerland) was overlaid on hESCs that 
had differentiated for 12 days. Collagen was allowed to form 
a gel by incubating for 30 min at 37˚C in a CO2 incubator. 
Sufficient medium was added to the wells and cells were 
subsequently cultured for 5 days.
Isolation and culture of hMSCs. Foetal pancreas samples 
from mid‑trimester therapeutic terminations of pregnancy 
were obtained from the Royal Infirmary of Edinburgh with 
informed consent from patients and approval of the Local 
Research Ethics Committee. hMSCs were isolated as described 
previously (9). In brief, the pancreas was collected in ice‑cold 
medium, finely sliced and incubated for 3 days undisturbed. 
Thereafter, plastic‑adherent hMSCs were maintained in 
DMEM (Biosera) with 10% FBS.
Differentiation of hMSCs to hepatocytes. Cells from 
passages 6‑15 were used for hepatic differentiation. Hepatic 
differentiation was carried out as previously described (2). 
Induction was initiated when cells were 80% confluent 
by treating hMSCs with differentiation medium [DMEM 
containing 20 ng/ml hepatocyte growth factor, 10 ng/ml 
basic fibroblast growth factor (PeproTech) and nicotinamide 
(0.61 g/l) (Sigma)] for 7 days. Subsequently, cells were 
cultured in maturation medium [DMEM containing 
20 ng/ml oncostatin M, 1 mmol/l dexamethasone (Sigma) 
and 1X Insulin‑Transferrin‑Selenium (Invitrogen Life 
Technologies)]. Cells were cultured for ≤41 days in differentia‑
tion medium and the medium was changed twice/week.
Isolation and culture of foetal hepatocytes. Livers from 
mid‑trimester therapeutic terminations of pregnancy were 
obtained from the Royal Infirmary of Edinburgh with 
informed consent from patients and approval of the Local 
Research Ethics Committee. Foetal hepatocytes were isolated 
as described previously (10). In brief, livers were collected in 
ice‑cold Williams' E medium (Invitrogen Life Technologies), 
dissected free of fibrous material, finely sliced and washed in 
Hanks' balanced salt solution (HBSS) to remove the red blood 
cells. Tissue fragments were digested with 0.1% collagenase 
type II (Worthington Biochemical Corporation, Lakewood, 
NJ, USA) in HBSS. Digestion was stopped by the addition 
of DMEM with 10% FBS. Cells were centrifuged and resus‑
pended in Williams' E medium supplemented with 10% FBS, 
50 U/ml penicillin, 50 mg/ml streptomycin, 2 mmol/l gluta‑
mine, 1X Insulin‑Transferrin‑Selenium (all from Invitrogen 
Life Technologies) and 10‑7 M dexamethasone. Viability was 
determined with 0.2% trypan blue using a Neubauer hemo‑
cytometer. Cells (2.7x106 cells/cm2) were cultured at 37˚C in 
5% CO2 on collagen‑coated plates [for coating plates, 250 µl 
of collagen solution (type I collagen, 1.5 mg/ml) was added 
to the wells, excess solution removed and plates incubated at 
37˚C for 1 h].
Estimation of secreted proteins by enzyme‑linked immunosor‑
bent assay. Cells were cultured in 12‑well plates in 500 µl of 
appropriate media and the supernatant was collected for the 
protein assay after 24 h. Hepatic proteins were measured using 
sandwich enzyme‑linked immunosorbent assays (ELISAs), as 
described by the manufacturer (Dako, Glostrup, Denmark). 
High‑binding EIA plates were coated with a rabbit anti‑human 
antibody (Dako) specific for the protein of interest (Dako) 
overnight at 4˚C. Sample supernatants were diluted 1:10 and 
added to 96‑well plates in triplicate. Plates were subsequently 
incubated for 2 h at room temperature. Peroxidase‑conjugated 
rabbit anti‑human antibody directed against the appropriate 
protein (Dako) was added and the plates were incubated for 
1 h at room temperature. The substrate o‑phenylenediamine 
was added and the reaction was stopped with 0.5 M sulphuric 
acid. The plates were read at 490 nm with a reference wave‑
length of 630 nm using MRX II Endpoint software (Dynex 
Technologies,Chantilly, VA, USA). To normalise the ELISA 
results, cells were lysed and the total protein was estimated 
using the DC protein assay kit (Bio‑Rad, Hercules, CA, USA).
Immunostaining and flow cytometry. For immunostaining, 
cells were fixed in 4% paraformaldehyde for 10 min at room 
temperature and washed with phosphate‑buffered saline. 
After blocking with 2% appropriate serum, cells were incu‑
bated with the primary antibody at 4˚C overnight followed 
by incubation with the appropriate secondary antibody for 
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1 h at room temperature. Nuclei were counterstained with 
4',6‑diamidino‑2‑phenylindole. For flow cytometry, cells 
were harvested and incubated in blocking buffer containing 
2% rabbit serum for 30 min followed by incubation for 
30 min with the primary antibody, according to the manufac‑
turer's instructions. The cells were counterstained with rabbit 
anti‑mouse secondary antibody for 30 min and were analysed 
in a Beckman Coulter EPICS flow cytometer (Brea, CA, USA) 
after washing. Primary antibodies were replaced with the 
corresponding immunoglobulin G antibodies for the control 
conditions. Antibodies used for immunostaining and flow 
cytometry are listed in Table I.
Excretion of fluorescein diacetate. The functional reconsti‑
tution of bile canaliculi was assessed by the localisation of 
secreted fluorescein within the bile canaliculi. Cells were 
treated with fluorescein diacetate (10 µg/ml) (Sigma) for 
10 min and immediately observed by fluorescence microscopy 
(DM IRB; Leica, Mannheim, Germany) to visualise fluores‑
cein localisation.
RNA isolation and reverse transcription‑polymerase chain 
reaction (RT‑PCR). Total RNA was isolated using the TRI 
reagent (Sigma) following the manufacturer's instructions. 
cDNA was synthesised using 1 mg total RNA with RT in 
a 20 ml volume following the manufacturer's instructions 
(Promega Corporation, Madison, WI, USA). The PCR was 
performed using the primer sequences and PCR conditions 
provided in Table II for 35 cycles. PCR products were analysed 
on a 2% agarose gel and the product size was estimated using 
a 100‑bp DNA ladder.
Quantitative PCR (qPCR) analysis. qPCR was performed 
according to the TaqMan® Fast Universal PCR Master mix 
instructions. The reaction mixture was prepared and PCR 
amplification was performed using the TaqMan® Gene 
Expression Assay mix for hepatocyte nuclear factor 4α 
(HNF4α), cytochrome P450 2D6 (CYP2D6), β2‑macroglobulin 
and β‑actin. The optimal baseline and threshold for each 
gene was set appropriately and the cycle threshold (CT) value 
was determined. The CT value of each sample was analysed 
and the sample group CT mean and standard deviation were 
calculated. β2‑macroglobulin was considered as the reference 
gene (β2‑macroglobulin showed the same level of expression 
in all the samples: CT standard deviation <1). The gene tran‑
scripts were quantified by ΔΔCT analysis, normalised with 
adult human hepatocytes and the results are expressed as fold 
change.
Table I. Antibodies and the dilutions used.
Antibody Catalogue no. Supplier Country Dilution
Alexa Fluor 594 F(ab)2 fragment A11020 Molecular Probes/Invitrogen USA 1:100
of goat anti‑mouse IgG (H+L)  Life Technologies  
Alexa Fluor 594 goat anti‑rabbit IgG A11037 Molecular Probes/ Invitrogen USA 1:100
  Life Technologies  
Anti‑human albumin FITC conjugated CLFAG2140 Cedarlane Canada 1:50
Anti‑mouse IgG FITC conjugated F2883 Sigma USA 1:50
Monoclonal anti‑human hepatocyte NCL‑HSA Novocastra/Leica Germany 1:20
specific antigen 
Monoclonal mouse anti‑human CK18 M7010 Dako Denmark 1:20
Mouse anti‑CD13 MCA1270 ABD Serotec UK 1:100
Mouse anti‑human CD105 MCA1557 ABD Serotec UK 1:50
Mouse anti‑human CD117 MCA1841 ABD Serotec UK 1:20
Mouse anti‑human CD29 MCA1949GA ABD Serotec UK 1:100
Mouse anti‑human CD31 (PECAM‑1) MCA1738 ABD Serotec UK 1:100
Mouse anti‑human CD34 MCA547G ABD Serotec UK 1:200
Mouse anti‑human CD44 MCA89 ABD Serotec UK 1:20
Mouse anti‑human CD45 MCA87GA ABD Serotec UK 1:50
Mouse anti‑human CD49b MCA743GA ABD Serotec UK 1:100
Mouse anti‑human CD54 MCA1615GA ABD Serotec UK 1:100
Mouse anti‑human CD90 MCA90 ABD Serotec UK 1:50
Mouse anti‑human DPP4 (CD26) 555435 BD Pharmingen USA 1:100
Mouse IgG1‑negative control MCA928 ABD Serotec UK 1:100
Mouse IgG2a‑negative control MCA929 ABD Serotec UK 1:100
Mouse monoclonal antibody to MRP2 ab3373 Abcam UK 1:250
Rabbit polyclonal to ZO‑1 ab59720 Abcam UK 1:25
IgG, immunoglobulin G; FITC, fluorescein isothiocyanate; CK18, cytokeratin 18; CD, cluster of differentiation; DPP4, dipeptidyl peptidase 4; 
MRP2, multidrug resistance‑associated protein 2; ZO‑1, zona occludin 1.
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Periodic‑acid Schiff (PAS) staining. Culture dishes containing 
cells were fixed in 4% formaldehyde and permeabilised with 
0.1% Triton X‑100 for 10 min. Samples were oxidised in 2% 
periodic acid for 5 min, treated with Schiff's reagent for 15 min 
and rinsed in deionised water for 5 to 10 min. Samples were 
counterstained with Mayer's haematoxylin for 20 sec, rinsed 
and assessed by light microscopy.
Indocyanin uptake. To determine the cellular uptake of 
indocyanin green (ICG; Sigma), 1 mg/ml of ICG in DMEM 
containing 10% FBS was added to cell cultures and incubated 
at 37˚C for 15 min. Cells were subsequently rinsed and cellular 
uptake of ICG was examined by microscopy.
Statistical analysis. Data obtained from 3 independent 
experiments with 3 replicates were evaluated by Student's 
t‑test. Data are expressed as mean ± standard deviation and 
P<0.05 was considered to indicate a statistically significant 
difference.
Results
Characterisation of hMSCs. MSCs were isolated from 
human foetal pancreas by plastic adherence and were char‑
acterised for the expression of essential MSC markers by 
flow cytometry (11,12). hMSCs were positive for cluster of 
differentiation 90 (CD90) (90±1%), CD105 (56±12%), CD49b 
(95±1%), CD73 (10±2%), CD29 (70±10%), CD13 (78±5%) and 
CD44 (96±1%) and were negative for CD34, CD117, CD31 and 
CD45 (Fig. 1).
Differentiation of hMSCs to hepatocytes. Although MSCs 
are highly proliferative, their growth slows during differentia‑
tion. During the initial phase of differentiation (the first week 
post‑induction), the fibroblast spindle morphology of hMSCs 
became more broad and elongated. During the maturation 
phase, in the presence of oncostatin M and dexamethasone, a 
retraction of elongated ends was observed and the cells devel‑
oped a cubical morphology by the second week post‑induction. 
Following prolonged culture, the hepatic morphology further 
matured with a polygonal shape and the cells became much 
more compact (Fig. 2A).
The expression of hepatic markers by hMSC‑derived hepa‑
tocytes (mDHs) was analysed. mDHs were positive for albumin, 
cytokeratin 18 (CK18) and hepatocyte‑specific antigen, 
confirming their hepatic differentiation (Fig. 2B). Furthermore, 
flow cytometry showed that 86±4% of MSC‑derived hepa‑
tocytes were positive for albumin, confirming the efficient 
hepatic differentiation of hMSCs (Fig. 2C).
The glycogen storage function was also examined in mDHs 
using PAS staining. mDHs exhibited evident glycogen storage 
(Fig. 2D), a function of the liver in carbohydrate metabolism. 
As hepatocytes are the major cells involved in xenobiotic 
metabolism, the uptake of xenobiotic compounds by mDHs 
was tested using ICG. MSC‑derived hepatocytes exhibited 
evident indocyanin uptake (Fig. 2E), confirming their ability 
to uptake xenobiotic compounds. RT‑PCR analysis confirmed 
that differentiated hMSCs expressed various hepatic genes, 
including α‑fetoprotein (foetal form of serum albumin), 
albumin (a serum protein produced by hepatocytes), CK18 
(hepatic cytoskeleton protein), carbomyl phosphate synthase 
Table II. Primer sequence, product length and annealing temperature.
Gene Primer sequence Product length, bp Annealing temperature, ˚C
ALB 5'‑TGAGAAAACGCCAGTAAGTGAC‑3' 265 49
 5'‑TGCGAAATCATCCATAACAGC‑3'  
CPS 5'‑TGAGGGATGCTGACCCCATT‑3' 255 53
 5'‑CATTGTTGGCGTTGAGCCAG‑3'  
CYP1A1 5'‑TTCGTCCCCTTCACCATC‑3' 302 49
 5'‑CTGAATCCACCCGTTGC‑3'  
CK18 5'‑CCCGCTACGCCCTACAGAT‑3' 271 53
 5'‑ACCACTTTGCCATCCACTATCC‑3'  
CK19 5'‑TCCAGATGAGCAGGTCCGAGGTTA‑3' 281 57
 5'‑GCTGCGGTAGGTGGCAATCTCC‑3'  
HNF4α 5'‑GCCTACCTCAAAGCCATCAT‑3' 275 53
 5'‑GACCCTCCCAGCAGCATCTC‑3'  
MRP2 5'‑ACAGAGGCTGGTGGCAACC‑3' 227 54
 5'‑ACCATTACCTTGTCACTGTCCATGA‑3'  
TDO 5'‑GGTTTAGAGCCACATGGATT‑3' 425 62
 5'‑ACAGTTGATCGCAGGTAGTG‑3'  
AFP 5'‑GCTTGGTGGTGGATGAAACA‑3' 157 50
 5'‑TCCTCTGTTATTTGTGGCTTTTG‑3'  
ACTB 5'‑GCACTCTTCCAGCCTTTC‑3' 385 51
 5'‑AGAAAGGGTGTAACGCAACTAAG‑3'  
bp, basepair; ALB, albumin; CPS, carbomyl phosphate synthetase 1; CYP1A1, cytochrome P450 1A1; CK18, cytokeratin 18; HNF4α, hepatocyte 
nuclear factor 4α; MRP2, multidrug resistance‑associated protein 2; TDO, tryptophan 2,3‑dioxygenase; AFP, α‑fetoprotein; ACTB, β‑actin.
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Figure 1. Characterisation of mesenchymal stem cells (MSCs). MSCs isolated from human foetal pancreas were characterised by flow cytometry. The black 
and gray histograms represent isotype control and test, respectively. Inset value denotes the percentage of the positive population. MSCs were positive for 
cluster of differentiation 90 (CD90) (90±1%), CD105 (56±12%), CD49b (95±1%), CD73 (10±2%), CD29 (70±10%), CD13 (78±5%) and CD44 (96±0.3%) and 
were negative for CD34 (1±1%), CD117 (1±1%), CD31 (0.3±0.6%) and CD45 (1±2%). IgG, immunoglobulin G; FITC, fluorescein isothiocyanate.
Figure 2. Characterisation of human mesenchymal stem cell (hMSC)‑derived hepatocytes. (A) Phase contrast images showing the change in morphology during 
differentiation. (B) Immunostaining showing the expression of ALB, CK18, hepatocyte‑specific antigen (HSA) and CD90 on day 41. Immunoglobulin G (IgG) 
represents the negative control. (C) Flow cytometry showing the expression of albumin on day 41. Bright field image showing (D) positive periodic‑acid Schiff 
staining (pink) and (E) indocyanin green uptake (arrowhead point cells showing indocyanin uptake) on day 41. In all the images, the scale bar denotes 100 µm. 
(F) Reverse transcription‑polymerase chain reaction showing the expression of hepatic genes on day 41. Actin, β‑actin; HNF4α, hepatocyte nuclear factor 4α; 
CYP1A1, cytochrome P450 1A1; ALB, albumin; CK18, cytokeratin 18; AFP, α‑fetoprotein; CK19, cytokeratin 19; CPS, carbomyl phosphate synthetase 1; 
MRP2, multidrug resistance‑associated protein 2; mDH, hMSC‑derived hepatocytes; hMSC, undifferentiated hMSCs; ‑RT, negative reverse transcription; 
HepG2, HepG2 cells; FITC, fluorescein isothiocyanate.
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(an enzyme of urea cycle), cytochrome P450 1A1 (CYP1A1; an 
enzyme involved in xenobiotic metabolism), HNF4α (hepatic 
transcription factor) and MRP2 (export protein) (Fig. 2F).
Differentiation of hESCs to hepatocytes. For differentiation, 
hESCs routinely cultured without feeder cells were treated 
with Activin A and Wnt‑3A for 3 days. The cells proliferated 
extensively and reached a confluency of 80‑90% during the 
initial 3 days (priming stage). Furthermore, the shape of the 
cells became spiky and triangular during this stage. The cells 
were subsequently changed to SR‑DMSO differentiation 
medium and cultured for 5 days. Cell death was observed 
during the initial 24 h in differentiation medium, although cell 
death was lower in cultures with higher confluency and better 
cell‑cell contacts. Cells in differentiation medium gradually 
exhibited a morphological change from a triangular to a 
polygonal outline (Fig. 3A). Medium was finally changed to 
maturation medium and the cells were cultured for 10 days, 
during which they exhibited the characteristic hepatocyte 
morphology; polygonal shape with large nuclei.
One of the functions of hepatocytes in the liver is the 
secretion of plasma proteins, such as albumin (essential for 
maintaining blood osmolarity), α‑fetoprotein (the major 
protein of foetal serum), α2‑macroglobulin (a protease 
inhibitor) and fibronectin (an extracellular protein capable of 
binding to receptor proteins). To examine the secretion of these 
hepatic proteins by hESC‑derived hepatocytes (eDHs), the 
culture medium from these cells was analysed by ELISA. The 
secretion of plasma proteins by eDHs significantly increased 
at different stages of differentiation, and this secretion peaked 
during the later differentiation stage (Fig. 3B).
PAS staining revealed evident glycogen storage in eDHs 
(Fig. 3C). eDHs also exhibited evident indocyanin uptake, 
confirming the generation of functional hepatocytes (Fig. 3D). 
Flow cytometry showed that 80±5% of eDHs were positive 
for albumin, confirming the efficient hepatic differentiation of 
hESCs (Fig. 3E). Furthermore, PCR analysis revealed that eDHs 
expressed HNF4α (a hepatic transcription factor), CYP1A1 (an 
enzyme involved in xenobiotic metabolism), albumin (a serum 
protein produced by hepatocytes), α‑fetoprotein (a major foetal 
serum protein), MRP2 (also known as canalicular multispe‑
cific organic anion transporter 1 or ATP‑binding cassette 
subfamily C member‑ABCC2), tryptophan 2,3‑dioxygenase 
(an enzyme involved in amino acid metabolism) and carbomyl 
phosphate synthase (an enzyme involved in the urea cycle) 
(Fig. 3F).
Polarisation of stem cell‑derived hepatocytes. Polarisation of 
ESC‑derived hepatocytes was evaluated by the expression of 
the tight junction protein ZO‑1 and the apical export protein 
MRP2 and bile canalicular protein DPP4. The functional 
ability of formed bile canaliculi was further evaluated by 
Figure 3. Characterisation of embryonic stem cell‑derived hepatocytes. (A) Phase contrast images showing the change in morphology during differentiation. 
(B) Human embryonic stem cell (hESC)‑derived hepatocytes (eDHs) showing the secretion of hepatic proteins. The x‑axis represents the day of differentiation 
and the y‑axis represents protein concentration (ng/ml/mg of total protein). (C) Bright field image showing periodic‑acid Schiff stained eDHs (arrow with the 
tail points to eDHs and arrow without the tail points to differentiation resistant hESCs) on day 17. (D) Bright field image showing indocyanin green uptake on 
day 17. In all the images, the scale bar denotes 100 µm. (E) Flow cytometry showing the expression of albumin on day 17. (F) Reverse transcription‑polymerase 
chain reaction showing the expression of hepatic genes on day 17. HNF4α, hepatocyte nuclear factor 4α; CYP1A1, cytochrome P450 1A1; ALB, albumin; AFP, 
α‑fetoprotein; MRP2, multidrug resistance‑associated protein 2; TDO, tryptophan 2,3‑dioxygenase; CPS, carbomyl phosphate synthetase 1; Actin, β‑actin; 
eDH, hESC‑derived hepatocytes; EC, undifferentiated hESCs; ‑RT, negative reverse transcription; HepG2, HepG2 cells; IgG, immunoglobulin G; FITC, 
fluorescein isothiocyanate.
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accumulation of fluorescein. eDHs cultured as a monolayer 
expressed the tight junction protein ZO‑1 (Fig. 4A), however, 
they did not show localised expression of MRP2 (Fig. 4B) and 
DPP4 (Fig. 4C) at their apical sides. Additionally, fluorescein 
accumulation was not visible in these cells (Fig. 4D).
Although mDHs showed the expression of tight junc‑
tion protein ZO‑1, the expression was not localised to the 
cell borders (Fig. 5A). Similarly, MRP2 expression was not 
localised to the apical side of the cell (Fig. 5B) and the DPP4 
expression was not observed (Fig. 5C). mDHs were also not 
able to localise fluorescein (Fig. 5D).
Foetal hepatocytes showed expression of tight junctions 
at cell borders (Fig. 6A) and localised expression of MRP2 
(Fig. 6B) and DPP4 (Fig. 6C) at the apical side of the cell. 
In addition, foetal hepatocytes showed fluorescein excretion 
localised to bile canaliculi (Fig. 6D).
In the HepG2 hepatic cell line, expression of the tight 
junction protein ZO‑1 was not uniform (Fig. 7A) and MRP2 
(Fig. 7B) and DPP4 (Fig. 7C) expression was confined between 
a few cells.
Secretion of hepatic proteins by stem cell‑derived hepatocytes. 
The functionality of eDHs, mDHs, human foetal hepatocytes 
and HepG2 cells were compared by analysing the secretion 
of hepatic proteins (albumin, prealbumin, α‑fetoprotein, 
fibrinogen, haptoglobulin, α2‑macroglobulin and fibronectin) 
by ELISA (Fig. 8). The secretion of mature hepatic proteins 
albumin, fibrinogen and haptoglobulin was higher in foetal 
hepatocytes, while α2‑macroglobulin secretion was higher 
in HepG2 cells. Higher secretion of premature hepatic 
proteins, prealbumin and α‑fetoprotein was observed in eDHs. 
MSC‑derived hepatocytes showed extremely low expression 
of all hepatic proteins.
Expression of hepatic genes by stem cell‑derived hepato‑
cytes. The expression of hepatic genes (MRP2, HNF4α and 
Figure 4. Polarisation of differentiated human embryonic stem cell (hESC). Fluorescence images showing the expression of (A) zona occludin 1 (ZO‑1), 
(B) multidrug resistance‑associated protein 2, (C) dipeptidyl peptidase 4 and (D) the excretion of fluorescein by hESC‑derived hepatocytes on day 17. (E) The 
negative control. The arrowhead points to the localised expression of ZO‑1. Scale bar denotes 50 µm.
  A   B   C
  D   E
Figure 5. Polarisation of differentiated human mesenchymal stem cell (hMSC). Fluorescence images showing the expression of (A) zona occludin 1, (B) multi‑
drug resistance‑associated protein 2, (C) dipeptidyl peptidase 4 and (D) the excretion of fluorescein by hMSC‑derived hepatocytes on day 41. (E) The negative 
control. Scale bar denotes 100 µm.
  A   B   C
  D   E
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CYP1A1) by MSC‑derived hepatocytes, eDHs, human foetal 
hepatocytes and HepG2 cells were examined by RT‑PCR 
(Fig. 9A).
In order to validate the RT‑PCR result for HNF4α and 
CYP enzyme expression, qPCR analysis was performed. 
qPCR analysis confirmed that HNF4α expression was in 
Figure 6. Polarisation of human foetal hepatocytes. Representative fluorescence images showing the expression of (A) zona occludin 1, (B) multidrug resis‑
tance‑associated protein 2, (C) dipeptidyl peptidase 4 and (D) the excretion of fluorescein by human foetal hepatocytes on day 3. (E) The negative control. The 
arrowhead points to the localised expression of corresponding protein/fluorescein localization. Scale bar denotes 50 µm. Top right inset is the zoomed view 
of the marked area.
Figure 7. Polarisation of HepG2 cells. Representative fluorescence images showing the expression of (A) zona occludin 1, (B) multidrug resistance‑associated 
protein 2, (C) dipeptidyl peptidase 4 and (D) the excretion of fluorescein by HepG2 cells. (E) The negative control. The arrowhead points to the localised 
expression of corresponding protein/fluorescein localization. Scale bar denotes 50 µm. Top right inset is the zoomed view of the marked area.
  A   B   C
  D   E
  A   B   C
  D   E
Figure 8. Secretion of hepatic proteins by stem cell‑derived hepatocytes. ELISA results showing the secretion of hepatic proteins. The x‑axis represents the 
cell type. The y‑axis represents the secreted protein concentration (ng/ml/mg protein). FH, foetal hepatocyte; HepG2, HepG2 cell line; eDH, hESC‑derived 
hepatocytes; mDH, hMSC‑derived hepatocytes.
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the order: HepG2 cells >foetal hepatocytes >eDHs >mDHs 
(Fig. 9B). qPCR analysis also confirmed the higher expression 
of CYP2D6 by eDHs compared to the HepG2 cells and foetal 
hepatocytes (Fig. 9C).
Effect of extracellular matrix in polarising eDHs. To evaluate 
the effect of extracellular matrix in polarising eDHs, the polarity 
of sandwich‑cultured eDHs was assessed by the expression of 
ZO‑1, DPP4 and fluorescein excretion (Fig. 10). Apart from 
ZO‑1 expression, eDHs showed modest localised expression 
of DPP4. eDHs also exhibited localised fluorescein excretion 
at their apical sides. The results confirm the ability of eDHs 
to form tight junctions (indicated by ZO‑1 expression), hepatic 
polarity (indicated by localised DPP4 expression) and functional 
bile canaliculi (indicated by localised fluorescein excretion).
Discussion
Similar to other epithelial cells, adult hepatocytes are polarised 
with an apical and basolateral surface, separated by tight junc‑
tion proteins. In the liver, the apical poles of hepatocytes join 
to form channels (bile canaliculi), through which bile salts and 
other metabolites are expelled. Tight junction proteins support 
the formation of hepatic polarity by sealing neighbouring cells 
to prevent intermembrane diffusions, thus segregating bile 
canaliculi and cellular lumen. They also promote differential 
expression of membrane proteins on the apical and basal side 
of the hepatocytes. Due to this membrane compartmentalisa‑
tion, export proteins that are actively involved in excreting bile 
salts/xenobiotic compounds are localised to the canalicular 
side of hepatocytes. The present study aimed to evaluate the 
hepatic functions and polarity of stem cell‑derived hepatocytes 
(eDHs and mDHs) and foetal heptocytes.
The hESC line RCM1 (13) was used for the study. RCM1 
cells were differentiated using the same protocol that was 
developed for differentiating hESCs and pluripotent stem cells 
to hepatocytes efficiently (3,4). During differentiation, RCM1 
cells showed prominent changes in morphology, expressed 
hepatic genes (albumin, α‑fetoprotein, carbomyl phosphate 
synthetase, MRP2, CYP1A1 and HNF4α) and secreted 
hepatic proteins (albumin, α‑fetoprotein, α2‑macroglobulin 
and fibronectin). They also exhibited mature hepatocyte char‑
acteristics, such as ICG uptake and glycogen deposition. These 
results confirmed the formation of functional hepatocytes 
from the RCM1 hESC line, as has been reported with other 
hES cell lines (3,4). However, the study showed the presence of 
differentiation‑resistant colonies within the eDH population, 
suggesting their unsuitability for transplantations, as the pres‑
ence of contaminating ES cell colonies can result in teratoma 
formation following transplantation (14).
Differentiation of hMSCs from bone marrow (2), umbilical 
cord blood (2), adipose tissues (15), dental pulp (16) and foetal 
bone marrow (17) to hepatocyte‑like cells has been reported 
previously. In the present study, human foetal pancreatic MSCs 
were isolated, cultured and analysed for the expression of 
essential MSC markers (11,12). Cells were positive for CD90, 
CD105, CD49b, CD73, CD29 and CD44, and were negative for 
CD34, CD117, CD31 and CD45, confirming that the cultured 
cells were MSCs. The differentiation of hMSCs to a hepatic 
fate was carried out by following the 3‑stage protocol described 
previously (2), however, the cells were maintained in maturation 
medium for 35 days. This extended period in the maturation 
Figure 9. Expression of hepatic genes by stem cell‑derived hepatocytes. (A) Reverse transcription‑polymerase chain reaction (RT‑PCR) showing the expression 
of hepatic genes in different cell types. Quantitative PCR (qPCR) analysis showing the relative expression of (B) HNF4α and (C) CYP2D6 in the different cell 
types. **P<0.05. Actin, β‑actin; CYP1A1, cytochrome P450 1A1; CYP2D6, cytochrome P450 2D6; HNF4α, hepatocyte nuclear factor 4α; MRP2, multidrug 
resistance‑associated protein 2; ‑RT, negative reverse transcription control; mDH, MSC‑derived hepatocytes; eDH, hESC‑derived hepatocytes; FH, foetal 
hepatocyte; HepG2, HepG2 cells.
  A   B   C
Figure 10. Polarisation of sandwich‑cultured embryonic stem cell‑derived hepatocytes. Fluorescence images showing the expression of (A) zona occludin 1, 
(B) dipeptidyl peptidase 4 and (C) the excretion of fluroescein by sandwich‑cultured embryonic stem cell‑derived hepatocytes on day 17. The arrowhead points 
to the localised expression of the corresponding protein/fluorescein localization. Scale bar denotes 50 µm. Top right inset is the zoomed view of the marked area.
  A   B   C
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medium was designed to enhance their functional maturity (2). 
During differentiation the morphology of hMSCs changed and 
the cells expressed albumin, CK18 and hepatocyte‑specific 
antigen, confirming hepatic differentiation. Flow cytometry 
analysis (albumin) and hepatic gene expression (albumin, 
α‑fetoprotein, carbomyl phosphate synthetase, HNF4α, 
CYP1A1 and MRP2) further confirmed the differentiation (16). 
The derived hepatocytes in the present study were negative for 
the expression of the biliary epithelial marker cytokeratin 19 
(a biliary epithelial cytoskeleton protein) (18), confirming 
that the differentiation was specific to the hepatocyte lineage. 
mDHs also exhibited facets of hepatic phenotype, such as ICG 
uptake and glycogen deposition (3). Such results confirmed the 
formation of functional hepatocytes from hMSCs isolated from 
the foetal pancreas. mDHs also expressed CD90, indicating a 
putative oval stem cell phenotype (10). However, they showed 
less secretion of hepatic proteins and a low level of CYP gene 
expression compared to other hepatocyte sources. They also 
showed heterogeneity in ICG uptake, indicating the functional 
heterogeneity of mDHs. This demonstrates their functional inef‑
ficiency for bioartificial liver (BAL) and in vitro toxicity studies, 
as these applications require highly functional hepatocytes.
In order to analyse the formation of functional hepatocyte 
polarity in stem cell‑derived hepatocytes, the expression of 
the tight junction protein ZO‑1, the bile canalicular export 
protein MRP2, bile canalicular protein DPP4 and excretion 
of fluorescein was examined. eDHs showed functional tight 
junctions, however, bile canaliculi formation was not observed. 
Extracellular matrix is a requisite for polarising epithelial 
cells (19,20) and collagen is widely used for polarising primary 
hepatocytes (21,22). Collagen was used to make a layer of extra‑
cellular matrix over eDHs in the present study. eDHs cultured 
with collagen showed modest localised expression of DPP4 
and fluorescein, confirming the formation of functional bile 
canaliculi in sandwich culture. These results show that the extra‑
cellular matrix has a profound influence even on the topology of 
stem cell‑derived hepatocytes and emphasise the requirement 
to provide specific extracellular matrix components and factors 
required by adult hepatocytes/epithelial cells for their functional 
maturation. A recent study (23) reports similar advantages using 
a 3‑dimensional (3D) system of culture.
Cell junctions are frequently involved in acute hepato‑
toxicity (24) and chronic hepatic diseases (25) and their loss 
is commonly evident during hepatocellular carcinoma (26). 
Therefore, junction proteins are used as an indicator for 
studying acute hepatotoxicity and chronic diseases, and for 
screening of non‑genotoxic carcinogens (27). As eDHs form 
tight junctions, they can be considered useful as in vitro‑based 
tight junction studies on acute and chronic hepatotoxicity 
and for screening genotoxic carcinogens. In addition, eDHs 
showed higher expression of CYP enzymes compared to the 
other alternate hepatocyte sources, confirming their suitability 
for in vitro toxicity studies and for BAL. As eDHs showed 
formation of polarity in sandwich culture, they may be able 
to perform better in the 3D environment of a BAL (28). As 
the 3‑stage protocol of ESC hepatic differentiation mimics 
the embryonic developmental stages of the hepatocyte (3), 
differentiated hESC can also be used as a tool to study the 
development and formation of tight junctions and the process 
of hepatocyte polarisation.
Human foetal hepatocytes are also considered as a potent 
alternative human hepatocyte source (29,30). A major source 
of human foetal hepatocyte is the liver of a therapeutically 
aborted foetus, and such abortions usually occur at the early 
stages of pregnancy. In the present study, human foetal hepa‑
tocytes isolated from the liver of terminated midtrimester 
foetuses showed albumin expression, glycogen storage and 
uptake of ICG confirming the efficient culture of functional 
human foetal hepatocytes (31). Additionally, human foetal 
hepatocytes showed hepatic polarisation with functional bile 
canaliculi formation. These results demonstrate the more 
mature aspects of human foetal hepatocytes compared to the 
pluripotent stem cell‑derived hepatocytes. However, based on 
protein secretion and gene expression data, foetal hepatocytes 
were not as functionally mature as adult hepatocytes.
HNF4α is an important hepatic transcription factor with 
active roles in hepatogenesis (32) and maintenance of hepatic 
functions (33,34). Among the stem cell‑derived hepatocytes 
examined in the present study, the expression of HNF4α was 
much lower in less polarised mDHs compared with the more 
polarised HepG2 cells and isolated human foetal hepatocytes. 
This demonstrates the profound role of HNF4α in creating 
and maintaining cell polarisation even during the develop‑
ment of hepatocytes from stem cells and supports the previous 
reports in mature hepatocytes (32,35,36). In addition, the 
more polarised cells, HepG2 and human foetal hepatocytes, 
showed less secretion of primitive hepatic proteins, such as 
α‑fetoprotein. These results correlate with previous studies on 
the effect of polarisation on hepatic functions, such as albumin 
secretion (37), bile secretion (38), glycogenolysis (39) and 
xenobiotic metabolism (26,40,41) in adult hepatocytes. This 
correlation between functional efficiency and polarisation may 
be due to the better protein trafficking and compartmentalisa‑
tion of cellular functions in polarised hepatocytes.
In conclusion, the present study has demonstrated that 
ESC‑derived hepatocytes form functional tight junctions, have 
higher secretion of hepatic proteins and improved expres‑
sion of CYP enzymes and hepatocyte transcription factor 
compared with mDHs. Collagen overlay to form a 2D‑matrix 
sandwich improves the functional polarisation of ESC‑derived 
hepatocytes and promotes the formation of bile canaliculi, 
emphasising the requirement for improved extracellular 
matrix environments, natural or synthetic, to further improve 
the function of pluripotent stem cell‑derived hepatocytes for 
toxicology studies and BAL devices.
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